MENU
AIM
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

AIM ImmunoTech (AIM) Ownership - Who owns AIM ImmunoTech?

AIM ImmunoTech Inc is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders, and to treat cancers for which there are currently inadequate or unmet therapies... Show more

Profile

Industry
N/A
Address
2117 SW Highway 484
Phone
+1 352 448-7797
Employees
28
Web
https://www.aimimmuno.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.72M
P/E Ratio
N/A
Total Cash
835K
Projected Growth
N/A
Total Debt
2.81M
Revenue
121K
Risk (Beta)
1.72
Dividend Yield
N/A
Total Cash/Share
0.31
Total Debt/Equity
N/A
Revenue/Share
0.18 USD as % of share price

Fundamentals

AIM
Capitalization
6.72M
P/E Ratio
N/A
Risk (Beta)
1.72
Dividend Yield
N/A
Total Cash
835K
Total Cash/Share
0.31
Total Debt
2.81M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.18%
Revenue
121K
ROE
N/A
Book Value
-6.55M
P/B Ratio
2.89
Cash Flow
N/A
Earnings
-24.88
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
0.10
Current Revenue Per Employee
1086.96
Dividends Per Share - Security
N/A
EBITDA
-15.32M
Float
N/A
Float - Current
N/A
Gross Income Margin
60.00
Revenue To Assets
-162.93
Shares Held By Institutions
650K
Shares Outstanding - Current
2.71M
Total Liabilities
10.7M
Total Volume MTD
N/A
Value
1
Gain YTD
-87.475
View a ticker or compare two or three
AIM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2117 SW Highway 484
Phone
+1 352 448-7797
Employees
28
Web
https://www.aimimmuno.com